We recognized that by using a ''split synthesis'' The one-bead one-peptide combinatorial library method repre-method on solid-phase peptide synthesis, each individsents a powerful approach to the discovery of binding peptides ual peptide-bead from the bead library will display for various macromolecular targets. It involves the synthesis of only one peptide entity (19, 20). With an appropriate millions of peptides on beads such that each bead displays detection scheme, the peptide-bead that interacts with only one peptide entity. The peptide-beads that interact with a a specific macromolecular target can be identified and specific macromolecular target are then isolated for structure isolated, and the peptide structure can be determined determination. We have applied this method to discovering pep-by microsequencing (19, 20). In the last few years, we tide ligands for several murine monoclonal antibodies: (i) anti-b-have successfully applied this combinatorial library endorphin (continuous epitope), (ii) anti-vmos peptide, (iii) anti-method in the identification of ligands for various tarhuman insulin (discontinuous epitope), and (iv) surface immuno-gets: streptavidin (20, 21), avidin (21), monoclonal antiglobulins (mk) of two murine B-cell lymphoma cell lines (antigen bodies (19, 20, 22, 23), gp IIb/IIIa integrin (24), MHCunknown). ᭧
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class I molecules (32) , protein kinases (31, 35) , proteases (unpublished result), and even a small organic dye molecule (30) . In this paper, we shall focus on the methodology, the underlying principle, and the applicaCombinatorial libraries of compounds can now be tion of this method in the study of B-cell epitopes. generated using chemical or biological methods and probed for functional or molecular interactions with target macromolecules. This new field has been ex-METHODS panding rapidly in many areas of biomedical research in the last few years. This very important emerging Materials technology has attracted enormous interest from academia and industry alike. Several reviews on the subTentaGel S (Rapp Polymere, Tubingen, Germany) (37) or Pepsyn gel (Milligen Inc., San Leandro, CA) ject have been written recently (1 -5) . Currently, there are four general approaches for preparing and were used for the synthesis of the peptide -bead library. Fmoc amino acids, with standard side-chain screening huge random combinatorial peptide libraries (i.e., 10 6 -10 8 entities): (i) the biologic peptide li-protecting groups, were obtained from Bachem (Torrance, CA), Advanced ChemTech (Louisville, KY), or brary method using filamentous phage (6 -9), plasmids (10), or polysomes (11); (ii) the combinatorial Propeptide (Vert-le-Petit, France). Benzotriazolyloxy-trisdimethylamino-phosphonium hexafluorolibrary methods requiring deconvolution: an iterative approach (12 -16), positional scanning (17), or or-phosphate (BOP), diisopropylethylamine (DIEA), diisopropyl carbodiimide (DIC), N-hydrobenzotriazole thogonal approach (17a); (iii) affinity column selection method (18); and (iv) the combinatorial library (HOBt), and piperidine were obtained from Advanced ChemTech. 2-Bromo-3-chloro-indolyl phosphate (BCIP) method based on the ''one-bead one-peptide'' concept, or the ''Selectide process' ' (19 -36) . This latter and nitroblue tetrazolium (NBT) were obtained from Ameresco (Solon, OH). Anti-b-endorphin monoclonal method will be the main subject of this paper.
antibody (MAb) (Clone 3-E7) was obtained from Boeh-propylene vials. Nineteen Fmoc-protected eukaryotic amino acids (all but cysteine) were then added separinger Mannheim (Indianapolis, IN). Dimethylsulfoxide (DMSO) was purchased from Sigma Chemical Co. rately into each of the resin aliquots. Cysteine was omitted to avoid inter-or intra-molecular crosslinking. (St. Louis, MO).
Threefold excess of amino acids and threefold excess of Peptide-Bead Library Synthesis each of BOP, DIEA, and HOBt were added to initiate the coupling reaction. In some experiments, HOBt and As mentioned earlier, a ''split synthesis'' method (19, DIC were used instead. In this case, a trace amount of 20, 38) was used for the preparation of the peptidebromophenol blue was added into the reaction mixture bead library. The basic scheme of the split synthesis to monitor the progress of the coupling reaction (41). method is shown in Fig. 1 . Standard Fmoc chemistry
The vials were tightly capped and mixed gently for 30 was used in the solid-phase peptide synthesis (39, 40) .
min to 1 h at room temperature until all beads turned The resins used were polyethyleneglycol-grafted polyfrom blue to colorless. The ninhydrin test (42) was then styrene resins (TentaGel S) or polydimethylacrylamide used to confirm the completion of the coupling reaction. resin (Pepsyn gel). Other resins that are compatible For the vials in which coupling reactions were incomwith peptide synthesis (organic solvents) and screening plete, the supernatant was gently removed, fresh Fmoc under aqueous conditions may also be used. Since amino acid, followed by BOP, DIEA and HOBt, was TentaGel S already has a polyethyleneglycol linker, an added, and the reaction was allowed to proceed for anadditional linker may not be needed. In some experiother hour. In general, double coupling was needed ments, an additional linker with b-alanine-e-aminocaonly on rare occasions. All the resin aliquots were then proic acid-b-alanine-e-aminocaproic acid was added ustransferred to a siliconized cylindrical glass vessel fiting Fmoc chemistry prior to the synthesis of the peptide ted with a frit at the bottom. Dried N 2 was bubbled library. As for the polydimethylacrylamide resin, the through the frit to mix the resin. After washing 81 resin was first mixed with ethylenediamine overnight.
with dimethylformamide (DMF), 20% piperidine (in The resin was then thoroughly washed, and e-aminoca-DMF) was added. Ten minutes later, piperidine was proic acid followed by b-alanine was coupled to the removed and the resins were washed 10 times with resin using Fmoc chemistry. The linkers in both cases DMF. The resins were then divided into 19 aliquots for were noncleavable. In our standard peptide library synthesis, the resins were distributed evenly into 19 poly-another cycle of coupling. Although we have synthe- sized and screened peptide libraries up to 18 amino the majority of the beads in the library remained colorless. acids long, most of our peptide libraries were less than 10 amino acids long. After all the randomization steps Under a dissecting microscope, the positive turquoise beads were isolated with a micropipette, washed with were completed, the N-a-Fmoc group was removed with 20% piperidine, and the side-chain protecting groups double-distilled water, immersed in 8 M guanidine hydrochloride, pH 2.0, for 20 min, washed with doublewere removed with reagent K (TFA:phenol:water:thiophenol:ethanedithiol, 82:5:5:5:2.5, v/w/v/w/v) (43) or a distilled water again, and destained with DMF. In some experiments, beads were recycled and restained mixture of TFA:phenol:anisole:ethanedithiol (94:2:2:2, v/w/v/v). The deprotected peptide-resin was then with the above protocol but in the presence of a competing antigen. Colorless beads were selected, treated with washed thoroughly with DMF, neutralized with 10% DIEA (in DMF), thoroughly washed again, and stored guanidine hydrochloride, and restained in the absence of competing ligand. Stained beads (true positive) were in 0.03% HCl in H 2 O at 4ЊC. In some experiments, cysteine was added to the amino and carboxyl termini of then isolated for microsequencing. the random peptide library. Cyclization of these cys- ]enkephalin, YGGFL (specific activity: 39.0 din or primary/secondary antibody system could be incorporated into the detection scheme. We have found Ci/mmol, New England Nuclear, Boston, MA), binding to 125-200 ng/ml anti-b-endorphin MAb in 1.0 ml of that the enzyme-linked colorimetric detection scheme is the most convenient method, is quick, and does not 40 mM Tris-HCl, 150 mM NaCl, pH 7.4, buffer containing 1.0 mg/ml bovine serum albumin, 0.1% (v/v) require any complicated instruments such as the fluorescent activated cell sorter. Details of the method for Tween 20, and 0.05% (w/v) sodium azide. Specific binding was defined as the difference between binding enzyme-linked detection have been detailed elsewhere (27) and are outlined below. measured in the presence or in the absence of 1.0 mM unlabeled [Leu 5 ]enkephalin. Bound radioligand was The peptide-bead library was thoroughly washed with double-distilled water to remove all the DMF. Gel-precipitated by the addition of a 10-fold excess of protein-G-Sepharose (Pharmacia) followed by an overatin (0.1% w/v) was then used to block any non-specific binding. In some experiments, bovine serum albumin night incubation (23-24ЊC). The protein-G-Sepharose was collected by centrifugation (13,000g for 5 min), and was used as a blocking agent. The beads were then mixed with the antibody-alkaline phosphatase com-the pellets were suspended in 250 ml 5% (v/v) acetic acid before transfer to vials for liquid scintillation counting. plex in PBS with 0.1% gelatin and 0.1% Tween 20 (Buffer A) with gentle mixing. After 1 to 24 h, the beads Binding data for saturation and inhibition studies were analyzed by weighted nonlinear regression methods uswere thoroughly washed with PBS and 0.1% Tween 20 (Buffer B), followed by TBS (Tris-buffered saline: 8 g ing appropriate one-site models reported by Knapp et al. (44) . K i values for inhibition binding constants were NaCl, 0.2 g KCl, and 3 g Tris-base in 1 liter water, pH 8.0). BCIP, a standard substrate in alkaline phos-calculated using the method of Cheng and Prusoff (45) .
Determination of peptide ligand affinities for the phatase buffer (5.85 g NaCl, 12.1 g Tris-base, 0.476 g MgCl 2 in 1 liter water, pH 8.5), was then added. The anti-vmos monoclonal antibody was performed with general methodology as described above. The anti-vmos bead suspension was then transferred to 10-20 polystyrene petri dishes (100 1 20 mm). No further mixing binding assay measured competitive ligand inhibition of 20 nM [ 3 H]N-acetyl-vmos peptide (see below) binding was needed. The reaction was allowed to proceed for up to 2 h. The reacting beads turned turquoise, while to 10 mg/ml anti-vmos monoclonal antibody in 1.0 ml of phosphate-buffered saline containing 0.1% (w/v) gel-have a tyrosine in the second position. An aromatic residue (phenylalanine or tryptophan) is preferred in atin, 0.1% (v/v) Tween 20, and 0.05% sodium azide. Nonspecific binding was measured in the presence of either position 4 or position 5. When an LDLDL-amino acid pentapeptide library was screened, two related 100 mM unlabeled vmos peptide. [
3 H]N-acetyl-vmos peptide was prepared by N-terminal acetylation of motifs emerged: YG_f_ and Y_ _F. In addition, two related discrete sequences were isolated: YGFGL and vmos peptide with [ 3 H]sodium acetate (specific activity: 2.52 Ci/mmol, New England Nuclear) and BOP and IyGGF. A third motif, Ya(N/Q)aW, was also apparent.
This latter motif is interesting as it is different from purified by reverse-phase high-performance liquid chromatography. The product coeluted with authentic those isolated from an all L-amino acid pentapeptide library. A DLDLD-amino acid library was also screened acetyl-vmos peptide and was found to have a specific activity of 2.50 Ci/mmol by measurement of the ratio and the identified motif was yGGF, again very similar to YGGF except that the N-terminal tyrosine is a Dof UV absorbance (OD 280 ) to the amount of tritium incorporated. The binding affinity of the radioligand was enantiomer. When an all D-amino acid pentapeptide library was screened, only one ligand was identified: determined by saturation analysis using five concentrations of [ 3 H]N-acetyl-vmos peptide that gave an av-wtGGy. This is interesting because it appears that it is a retro-inverso of YGGTW, a plausible L-ligand for erage kDa value of 0.848 { 0.156 mM for five measurements.
anti-b-endorphin MAb. The binding affinities of some of these ligands were determined. The YGGF motif has the highest binding affinity and is in the low nanomolar range (20). The binding affinity of many of the re-
RESULTS
maining ligands, on the other hand, is at least one to two orders of magnitude weaker than that of the YGGF Anti-b-endorphin MAb motif (23). Table 1 was used as a source from which anti-vmos MAb After incubation with the substrate (in this case BCIP plus NBT), 50 of the beads stained intensely blue. was purified (No. 165-28E7, SCRF 354, Lot No. 165-119 was obtained from Microbiological Associates, Twenty-four of these beads were physically removed, and the amino acid sequences for 11 of them were deBethesda, MD). The MAb was produced by immunizing mice with the 12-amino-acid peptide LGSGGFGSV-termined.
The anti-vmos ligand sequencing results are shown YKA, which corresponds to residues 100 to 111 of the vmos oncogene product. The peptide was conjugated in Table 2 . Since both valine and serine were purposely excluded in this peptide library, it is not surprising to a carrier protein prior to immunization. In ELISA testing, the anti-vmos MAb detects homologous se-that none of the 11 peptide ligand sequences identified resemble the native epitope (FGSVY). Although there quences of vmos, MOS, neu/HER-1, and HER-2 gene products. The epitope within the 12-amino-acid vmos were no repeats in the 11 peptide ligands, their sequences were nonrandom. Arginine and tyrosine occur peptide recognized by the anti-vmos MAb was mapped by using a commercially available multipin epitope frequently in these sequences. Furthermore, at least one and sometimes two arginines were present at the mapping kit first described by Geysen et al. (46) (Cambridge Research, Biochemical, Boston). Overlapping second and/or third position of each of these ligands.
Some of the positive ligands were synthesized, and peptide sets (tetrapeptides, pentapeptides, and hexapeptides) were used in this analysis. Using this their affinity for the anti-vmos MAb were determined with solution-phase binding studies (Table 3) . b-alamethod, the pentapeptide sequence FGSVY (i.e., residues 6-10 of the vmos dodecapeptide) was determined nine amide was added to the C-terminus of some of the ligands to simulate the ligand to which the antibody to be the epitope.
In our experiment, a restricted random library was binds on the bead. The affinity of the best anti-vmos peptide ligand identified was 2.5-fold less than that of used in which the amino acids valine and serine in the vmos epitope were purposely omitted. This restricted the native peptide (Table 3) . Although none of the peptide ligands tested have a K i value as low as that of random library has the following composition: GXXXXX-b-alanine-aminocaproic acid-ethylenediamine-the native vmos ligand, the results clearly demonstrate that by using a random library lacking some of the Pepsyn gel, wherein X is E, P, N, F, H, T, K, L, G, Y, A, M, R, or W. These 14 amino acids were carefully amino acids present in the native epitope, a series of structurally quite different peptide ligands of various chosen so that despite the absence of valine and serine, all the chemically different side-chain functionalities affinity for the anti-vmos MAb can still be identified. found in proteins were included: (i) asparagine was seAnti-insulin MAb (Discontinuous Epitope) lected but not glutamine; (ii) glutamic acid was selected Table 4 summarizes the data obtained from screenbut not aspartic acid; (iii) threonine was selected but ing four linear all L-amino acid peptide libraries using not serine; (iv) leucine was selected but not isolencine anti-insulin MAb (clone AE906) as a probe. This muor valine; and (v) methionine was selected but not cysteine. Since 14 amino acids were available for each of the five random coupling steps, the maximum number 
In addition general formula for the libraries used in these experiments was (X) n -b-e-b-e-TentaGel S. The peptide was there are several other discrete sequences identified from these screens. One sequence, CKFDWMAGGC, attached to the resin via a b-alanine-e-aminocaproic acid-b-alanine-e-aminocaproic acid linker (b-e-b-e). isolated from the octapeptide library, is interesting as it is very similar to the FDW_ _ motif identified from When a pentapeptide library was screened, two distinct motifs emerged: FDW_ _ (or FNW_ _) and _QDPR (or a linear pentapeptide library. Table 6 summarizes the data obtained from screen-_QNPR). When a hexapeptide library was screened, an additional motif was identified: _W_ _GF. In addition, ing other constrained peptide libraries, namely, the ''turn libraries.'' In this case, a D-proline is added in a discrete sequence SQHGIW was detected. Similar to the hexapeptide library, the predominant motifs identi-the middle of the peptide to promote a turn. In one case, the i / 2 position has a random D-instead of an fied from both the octapeptide and the decapeptide libraries were _ _ _W_ _GF and _ _ _ _ _W_ _GF, respec-L-amino acid. The predominant motif identified from these screens was _FQp_ _PG, whether the i / 2 positively.
In addition to linear peptide libraries, libraries with tion is a D-or an L-enantiomer. In addition, two discrete sequences that do not fit this motif were isolated. secondary structures were designed and screened. The results are shown in Tables 5 and 6 . The peptide librar- Table 7 shows the results of screening two all Damino acid hexa-and octapeptide libraries. Both of ies shown in Table 5 are cyclic peptide libraries having the following general formula: C-(X) n -C-b-e-b-e-Tenta-these libraries used glycine, instead of b-alanine-eaminocaproic acid-b-alanine-e-aminocaproic acid, as Gel S. Again, the peptide was attached to the TentaGel via a b-e-b-e linker. The peptide was cyclized by the linker. All the ligands identified from the hexapeptide library line up perfectly with the following motif: oxidation of the flanking cysteines to form a disulfide bond. The three distinct motifs isolated are high-_q_Gs(t)G. Threonine is very much preferred in the sixth position. Similarly, the ligands identified from lighted in Table 5 : CWD_GFG_C from the hepta-, C_ _ _ _HGVQC from the octa-, and CQDI_Y_ _ _ _C an octapeptide library have the same motif: q_Gs_G.
However, the alignment of the amino acids of these from the nonapeptide libraries. Interestingly, except for the CWD_GFG_C motif, which is related to the octapeptides is not perfect.
Unlike some of the ligands identified from the antib-endorphin MAb screen, the binding affinity of the ligands identified from the primary screen against The general formula for the peptide libraries used in this study a The general formula for the peptide libraries used in this study is (X) n -b-e-b-e-TentaGel S, where X is all 18 L-amino acids plus gly-is C(X) n C-b-e-b-e-TentaGel S, where C is cysteine and X is all 18 Lamino acids plus glycine, no cysteine. cine, no cysteine.
braries was designed and tested. The results are shown valuable tool for B-cell epitope mapping. During the split synthesis, the resin-beads are first divided into in Fig. 2 . As indicated earlier, a _W_ _GF motif was identified during the primary screen of a hexapeptide several aliquots, and individual amino acids are then added separately into each of the resin aliquots and library. Based on this primary motif, a secondary library with the structure XXXWXXGF was synthesized the reaction is driven to completion with excess amino acids. The resins are then mixed, washed, Na-Fmoc and screened under a higher stringency. Two motifs were readily identified: Q_IWG_GF and _ _ _WKYGF. deprotected, washed, and divided into several aliquots again for the next coupling. We recognized that with Based on these two motifs, two tertiary libraries were synthesized and screened under an even higher strin-this synthetic strategy, millions of peptide-beads can be synthesized rapidly, and at the end of the library gency: XXQXIWGXGF and XXXXWKYGF. The final motifs identified from these two tertiary screens were synthesis, each bead displays only one peptide entity.
Since each 120-mm bead contains approximately 100 S(R/K)Q_IWG_GF and NH_ _WKYGF. The binding affinities of these final ligands are approximately one to pmol peptide (or ú10 13 copies of the same peptide), there is more than enough peptide in each bead for two orders of magnitude better than those identified from the initial primary screen (47). structure determination. Typically, a pentapeptide library of 10 million beads can be synthesized and deproIdiotype-Specific Peptides for B-Cell Lymphoma tected in 2-3 days. Screening usually takes 1-2 days. We have recently reported the application of the Se-The rate-limiting step of this process is microsequenclectide process to identify peptide ligands for the sur-ing, as only 3-4 peptides (6-to 8-mers) can be microface immunoglobulins (idiotypes, m, k) of two murine sequenced each day. Alternatively, using a capping prolymphoma cell lines (WEHI-279 and WEHI-231) (36) . cess after each cycle of synthesis, it is possible to The result is shown in Table 8 . Both L-and D-amino determine the entire peptide sequence with mass specacid peptide libraries were screened. For the WEHI-trometry at a faster rate (48, 49). Since the rate-lim-279 idiotypes, only one predominant motif was identi-iting step is microsequencing, it is extremely important fied from the L-amino acid peptide library screen: to eliminate any false positive beads. This could be RW(I/F)D_. On the other hand, at least two distinct accomplished by using the screening method described motifs (Gr_ _ _w_ _ and _t_Gm_k_) and four other dis-in this paper or by using a dual-color screening apcrete sequences were identified when an all D-amino proach (34) . acid octapeptide library was screened. Similarly, for
The Selectide process is a parallel approach in which the WEHI-231 idiotype, one predominant motif (_WY_) millions of peptides are screened concurrently, and ofwas isolated from the L-amino acid peptide libraries, ten multiple distinct motifs can be identified with a and three distinct motifs were identified from the D-one-step screening process. This is clearly shown in amino acid octapeptide library screen (lw_ _pew(i/v), the anti-insulin MAb and lymphoma surface idiotype kwrGp_w, and wGey(i/v)_v).
results. In contrast, the iterative approach as pioneered by Geysen (12, 13) and Houghten (14) is a convergent approach in which multiple steps of synthesis and anal-
DISCUSSION

TABLE 7
One-Bead One-Peptide Combinatorial Library As illustrated in this paper, the one-bead one-peptide The general formula for the peptide libraries used in this study a The general formula for the peptide libraries used in this study is (X) n p(X) m G-TentaGel S, where X is all 18 amino acids plus glycine, is (x) n G-TentaGel S, where x is all 18 D-amino acids plus glycine, no cysteine. no cysteine; p is D-proline; and G is glycine.
distribution of the beads with just one bead per well. one predominant solution. If there are several distinct motifs, as in the case of the D-amino acid peptide librar-For peptide distribution in both stages, beads are transferred into the upper chambers of a vacuum conies for the lymphoma idiotypes (Table 8) , the positional scanning approach will likely yield uninterpretable re-trol 96-well filtration manifold (Model 09601, Millipore Corp., South San Francisco, CA), and the peptide filsults.
trates are collected in a 96-well plate underneath the manifold. Cleavage of the second linker (alkylester Solution-Phase Releasable Assay bond) is accomplished by addition of 0.2 M NaOH folIn addition to the on-bead binding assay as described lowed by neutralization, or alternatively, the secondin detail in this article, we have screened the peptidestage release can be achieved by overnight incubation bead library with a solution-phase releasable assay in ammonia vapors. After the second-stage bioassay, (50). This assay involves a two-stage sequential release positive wells from the test plate are identified and and testing system using 96-well microtiter plates.
referenced back to the individual bead of origin, which Each peptide-bead has three linkers; one is noncleavis then recovered from the master plate for sequencing. able (reserved for subsequent microsequencing) and
We have successfully used this method to identify pepthe remaining two can be cleaved orthogonally and sequentially under very mild conditions. In the first-stage release and testing, about 500 peptide-beads are pi- tide ligands for the anti-b-endorphin monoclonal anti-combining site. Unlike the anti-b-endorphin MAb system, in which only one predominant motif was identibody and gpIIb/IIIa integrin (50).
fied, the anti-insulin MAb system generated multiple Anti-b-endorphin MAb distinct motifs depending on the length of the libraries, Our initial work on the anti-b-endorphin MAb was whether it was an all D-amino acid or L-amino acid straightforward, as it recognizes a short linear motif peptide library, and whether there was a built-in sec-YGGF. High-affinity ligands (K d at low nanomolar ondary structure. For example, the _W_ _GF motif was range) were readily identified in our initial screen. not identified in a 5-mer library and was only identified Since the antibody used for screening was bivalent, in a §6-mer library, and C_ _ _ _HGVQC was identified even low-affinity ligands were detected (Table 1) . Many in a C(X) 8 C, but not a C(X) 7 C library. of the low-affinity ligands isolated show considerable Although there are multiple motifs for anti-insulin similarity to the parent epitope. However, for high-af-MAb identified from the L-amino acid peptide library, finity binding, YGGF is required. The all D-amino acid only one predominant motif was isolated from the Dligand, wtGGY (K d ú 100 mM), is interesting as it re-amino acid library: _q_Gs(t)G. The fact that there was sembles a retro-inverso structure of YGGTW. In gen-always at least one amino acid at the amino-terminal eral, we determine the structure of the isolated ligands side of q_Gs(t)G suggests that this first residue, alby microsequencing one individual peptide-bead. though variable, is extremely important. However, for the anti-b-endorphin ligands, in addition As indicated earlier, the binding affinity of ligands to microsequencing individual single beads, we have isolated from the primary screen against anti-insulin microsequenced up to approximately 90 beads concur-MAb was weak. Perhaps this is because this antibody rently and nevertheless were able to extract the bind-recognizes a discontinuous epitope that occupies a ing motif of YG_F (27). This is feasible because there larger space than a short peptide does. However, with is only one predominant motif. However, if there were the sequential screening approach using secondary and multiple motifs (e.g., the pentapeptide library screen tertiary libraries, we have been successful in identifor anti-insulin MAb; Table 4), the data will be ambigu-fying higher affinity ligands for anti-insulin MAb ( particularly if no clear-cut motif can be identified from the primary screen, is to screen ''homolog secondary Anti-vmos Peptide MAb library.'' In a ''homolog library,'' no specific amino acid In the case of the anti-vmos MAb, a peptide library is fixed and every position is randomized, but the synomitting two of the amino acids in the natural epitope thetic scheme is biased toward a specific sequence or was used. We nevertheless discovered a linear epitope sets of sequences of the initial leads (47). This approach of totally different sequences with affinity 50-fold is particularly valuable for rapid optimization of all the greater than the hexapeptide epitope and approxi-residues of the initial lead. mately equal in affinity to the full length 12-aminoLymphoma Cell Surface Idiotypes acid peptide antigen. The binding affinity of the antivmos peptide was dependent on (i) the presence or ab-
The antigens for the surface idiotypes of the two sence of a b-alanine linker at the carboxyl termini and lymphoma cell lines are unknown. Using the combina-(ii) whether it is in a carboxylamide or carboxylic acid torial peptide library method, we succeeded in isolating form. For example, the binding affinity of the carboxylic several peptide ligands for these surface idiotypes. acid form of GRRAYE is 4-fold better than that of its These ligands are specific for the cell line from which carboxylamide form. In contrast, the carboxylic acid the idiotype was isolated. Upon binding to an intact forms of GRRGME and GRRPYG was detrimental to cell, these peptides, in tetrameric form, were able to the binding affinities of these two peptides (Table 3) . trigger signal transduction, resulting in elevated proThis clearly demonstrates the complexity as well as the tein tyrosine phosphorylation (36) . We plan to use these versatility of macromolecular peptide interaction.
peptides as carriers for targeted therapy of B-cell lymphoma (36, 51) . From the therapeutic standpoint, Anti-insulin MAb the D-amino acid ligands are particularly attractive, as they are likely to be more stable to proteolysis in We have extensively tested the one-bead one-peptide combinatorial library method using anti-insulin MAb vivo.
As indicated earlier, for the anti-insulin MAb, only as a model system. This antibody was chosen because it is readily available and it recognizes a discontinuous one predominant motif was identified from D-amino acid peptide libraries, whereas multiple motifs were epitope. The result of these studies is shown in Tables 4 to 7 and Fig. 2 . Excess insulin can compete for the identified when L-amino acid peptide libraries were screened. In contrast, when the lymphoma idiotypes binding of all the peptide ligands to anti-insulin MAb, suggesting that all these ligands bind to the antigen (both WEHI-231 and WEHI-279) were used, multiple motifs were identified from the D-amino acid peptide endorphin is small and only peptides that closely resemble YGGF can interact or (ii) there are other potenlibraries and only one predominant motif was identified from the L-amino acid peptide libraries. Although tial interaction sites created by the various CDR loops but these ligands were not isolated because their bindthe native antigens for the two lymphoma idiotypes are unknown, it is conceivable that both antibodies recog-ing affinities are significantly weaker than that of YGGF. The former explanation is favored because very nize discontinuous epitopes, as multiple motifs have been identified from the library screen.
low-affinity ligands were indeed isolated but they all resemble YGGF (Table 1) . It is conceivable that the Mimotope Concept multiple different ligands identified from anti-insulin MAb interact with different CDR loops of the antibody There is a general belief that by employing combinatorial peptide library methods to map B-cell epitopes, molecule. Even though native insulin can compete for the binding of all these peptides (including the D-lione may be able to design small peptides for use as vaccines (52) . Mario Geysen first coined the term gands) to anti-insulin MAb, many of them probably have little resemblance to the structural feature of namimotopes, which he defined as ''a molecule able to bind to the antigen combining site of an antibody mole-tive insulin. That is, they may not be ''true mimotopes'' and may not be used as an immunogen for eliciting cule, not necessarily identical with the epitope inducing the antibody, but an acceptable mimic of the essential anti-insulin response. This concept is illustrated in Fig.  3 . Assuming that there are seven potential interaction features of the epitope'' (12). Experimentally, it was defined by screening combinatorial peptide libraries sites (formed by the various CDR loops) in the antiinsulin MAb, that native insulin interacts with only (Geysen's multipin iterative approach) with an antibody. However, there is no guarantee that the mimo-three of these sites (sites 2, 4, and 6), and that if we screen enough libraries and with enough diversities, tope can elicit an immune response against the native epitope. In order to be a ''true mimotope,'' it has to we can discover ligands for each of these seven potential interaction sites. Although insulin can compete for fulfill the following two criteria: (i) it mimics the antigenicity by binding to the antibody that recognizes the ligands identified for sites 2-6 (but not 1 and 7), ligands for sites 3 and 5 may bear no resemblance to the native epitope, and (ii) it mimics the immunogenicity by its ability to elicit a humoral immune response structural feature of native insulin and certainly will not be able to generate anti-insulin antibody when against the native epitope that it mimics. This second criteria is crucial if one plans to use the mimotopes as used as an immunogen. On the other hand, ligands for sites 2, 4, or 6 may mimic some structural features of vaccines. Based on the data reported in this paper, the mimotope concept certainly applies to antibodies that the native insulin molecule and may be able to elicit anti-insulin response. Work is underway in our labrecognize a small continuous epitope (e.g., anti-b-endorphin MAb) and perhaps may even be true for a small oratory to test whether the identified anti-insulin MAb peptides (Tables 4-7) are ''true mimotopes'' compact discontinuous epitope although there are little data to support the latter. In case of the anti-b-endor-or not. phin MAb, almost all the ligands isolated from a truly random library have close resemblance to the native epitope, YGGF. It is likely that immunogens based on any of these mimotopes (including the D-amino acid containing ligands) will elicit antibodies that cross-react with the native epitope. Perhaps one of the few exceptions may be the Ya(N/Q)a W motif, of which the only common features with the native epitope are an N-terminal tyrosine and an aromatic residue at the Cterminus. Work is currently underway in our laboratory to immunize animals with this peptide to see if antibodies against YGGF can be elicited.
In the case of anti-insulin MAb that recognizes a discontinuous epitope, multiple distinct motifs and several discrete sequences were identified (Tables 4-7) . None of these sequences have any sequence homology with the primary sequence of human or porcine insulin. The fact that only one predominant motif was identi- 
